Cargando…
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
Autores principales: | Alon, Michal, Arafeh, Rand, Lee, Joo Sang, Madan, Sanna, Kalaora, Shelly, Nagler, Adi, Abgarian, Tereza, Greenberg, Polina, Ruppin, Eytan, Samuels, Yardena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407687/ https://www.ncbi.nlm.nih.gov/pubmed/30863494 http://dx.doi.org/10.18632/oncotarget.26685 |
Ejemplares similares
-
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
por: Alon, Michal, et al.
Publicado: (2018) -
A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS‐mutant melanoma
por: Nagler, Adi, et al.
Publicado: (2019) -
NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membrane
por: Yakovian, Oren, et al.
Publicado: (2022) -
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
por: Kalaora, Shelly, et al.
Publicado: (2020) -
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)